2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (ADMIN-CORE)

2/2 药物开发和能力建设：UCR/CoH-CCC 合作伙伴关系 (ADMIN-CORE)

基本信息

批准号：
10469598
负责人：
ERNEST MARTINEZ
金额：
$ 28.88万
依托单位：
UNIVERSITY OF CALIFORNIA RIVERSIDE
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-02 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10469598
关键词：
Achievement Address African American African American student Antelopes Asian Black race California Cancer Center Support Grant Cancer Death Rates Cell Line Cellular biology Chicago City of Hope Comprehensive Cancer Center Clinical Trials Communities Conduct Clinical Trials Data Developmental Therapeutics Program Doctor of Medicine Doctor of Philosophy Documentation Ensure European Evaluation Faculty Funding Goals Grant Health Health Sciences Healthcare Hispanic Housing Illinois Joints K-Series Research Career Programs Latino Lead Leadership Logistics Minority Mission Monitor National Cancer Institute Not Hispanic or Latino Persons Physicians Pilot Projects Policies Policy Developments Politics Postdoctoral Fellow Principal Investigator Publications Reporting Research Research Personnel Resources Safety Science Scientist Site Testing Therapeutic Time TimeLine Toxicology Training Translational Research Underrepresented Minority Universities anticancer research cancer health disparity clinical trial participant disparity elimination drug development drug discovery education research health disparity human subject protection improved meetings member minority communities novel therapeutics professor programs stem cells success translational research program

项目摘要

ABSTRACT The mission of the Administrative Core is to facilitate the capacity building and training mission of the University of California Riverside (UCR) - City of Hope Comprehensive Cancer Center (CoH-CCC) P20 Program. Both UCR and CoH-CCC are committed to providing the P20 PIs and investigators with necessary resources including protected time and clerical assistance. The Administrative Core will provide scientific leadership, administration, and fiscal management. The Core will be led by P20 PI's, Ernest Martinez, Ph.D. (UCR) and Victoria Seewaldt, M.D. (CoH). The P20 PI's are both R01 funded and are committed to training of underrepresented minorities. External Advisory Board (EAB) and Internal Advisory Board (IAB) will help guide our P20 planning, implementation, and evaluation. Together, we will develop initial plans, set priorities, and implement and evaluate whether we meet our P20 goals and milestones. Our EAB leaders are well-qualified to guide our P20 Partnership. EAB members are world leaders in the health science of disparities and lead their own P20 and U54 grants. EAB members include: Elana Martinez, Ph.D. (UC San Diego), Lucio Miele, M.D. (LSU), Ricardo Richardson, Ph.D. (NCCU), and Robert Winn, M.D. (University of Illinois, Chicago). EAB leaders will meet on site yearly to evaluate progress of the P20. Our IAB members are senior leaders within UCR and CoH-CCC. UCR IAB members include: Dr. Kelechi Kalu, Ph.D., Vice Provost and Professor of Political Science and Dr. Frances Sladek, Professor of Cell Biology and Toxicology. CoH-CCC IAB leaders include David Horne, Ph.D., CoH-CCC Developmental Therapeutics Program and Beckman Therapeutic Director and Linda Malkas, Ph.D., Dean of Translational Science and External Affairs CoH-CCC and Board of Directors California Stem Cell Translational Research Program. IAB and P20 leaders will meet quarterly, or more frequently if needed, to provide strategic direction, policy development, and evaluation of our P20 Partnership Project.

抽象的行政核心的使命是促进能力建设和培训任务加州大学河滨分校 (UCR) - 希望之城综合癌症中心 (CoH-CCC) P20 程序。 UCR 和 CoH-CCC 均致力于为 P20 PI 和研究人员提供必要的信息资源，包括受保护的时间和文书协助。行政核心将提供科学领导、行政和财务管理。该核心将由 P20 PI 的 Ernest Martinez 博士领导。 (UCR) 和维多利亚·西瓦尔特 (Victoria Seewaldt) 医学博士 (CoH)。 P20 PI 均获得 R01 资助，并致力于培训代表性不足的少数群体。外部顾问委员会 (EAB) 和内部顾问委员会 (IAB) 将帮助指导我们的 P20 规划，实施、评估。我们将共同制定初步计划，确定优先事项，并实施和评估我们是否实现了 P20 目标和里程碑。我们的 EAB 领导人完全有资格指导我们的 P20 合作伙伴关系。 EAB 成员是以下领域的世界领导者差异的健康科学并领导他们自己的 P20 和 U54 拨款。 EAB 成员包括：Elana 马丁内斯博士（加州大学圣地亚哥分校）、Lucio Miele 医学博士（路易斯安那州立大学）、Ricardo Richardson 博士（NCCU）和罗伯特温恩，医学博士（伊利诺伊大学芝加哥分校）。 EAB 领导每年都会召开现场会议，评估项目进展情况 P20。我们的 IAB 成员是 UCR 和 CoH-CCC 的高级领导。 UCR IAB 成员包括： Dr. Kelechi Kalu 博士、副教务长兼政治学教授和 Frances Sladek 博士，Cell 教授生物学和毒理学。 CoH-CCC IAB 领导者包括 CoH-CCC Developmental 的 David Horne 博士治疗项目和 Beckman 治疗总监和 Linda Malkas 博士，转化学院院长科学与对外事务 CoH-CCC 和加州干细胞转化研究董事会程序。 IAB 和 P20 领导人将每季度举行一次会议，或者根据需要更频繁地举行会议，以提供战略方向、政策制定以及 P20 伙伴关系项目评估。